The vitamin D analog ED-71 is a potent regulator of intestinal phosphate absorption and NaPi-IIb

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5150-5156

  Brown, Alex J ^a   Zhang, Fanjie ^a   Ritter, Cynthia S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; ELDECALCITOL; MESSENGER RNA; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 2B; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DUODENUM; ILEUM; INTESTINE ABSORPTION; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SMALL INTESTINE; SMALL INTESTINE MUCOSA; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY;

ABSORPTION; ANIMALS; CALCITRIOL; INTESTINES; MALE; MICE; MICE, KNOCKOUT; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB; VITAMIN D DEFICIENCY;

EID: 84867815906     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1587     Document Type: Article

References (26)

1. 3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects. J Steroid Biochem Mol Biol 103:584-586
2. 3 analogue, 2-β-(3-hydroxy-propoxy)- calcitriol (ED-71): its biological activities and pharmacological effects on calcium metabolism. Contrib Nephrol 91:116-122
3. 3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 54:142-149
4. Uchiyama Y, Higuchi Y, Takeda S, Masaki T, Shira-Ishi A, Sato K, Kubodera N, Ikeda K, Ogata E 2002 ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 30:582-588 (Pubitemid 34270495)
5. Matsumoto T, Miki T, Hagino H, Sugimoto T, Okamoto S, Hirota T, Tanigawara Y, Hayashi Y, Fukunaga M, Shiraki M, Nakamura T 2005 A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 90:5031-5036 (Pubitemid 41262250)
6. 3 (eldecalcitol) is a potent regulator of calcium and phosphate metabolism. Calcif Tissue Int 89:372-378
7. Marks J, Debnam ES, Unwin RJ 2010 Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 299:F285-F296
8. Marks J, Srai SK, Biber J, Murer H, Unwin RJ, Debnam ES 2006 Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice. Exp Physiol 91:531-537
9. Kaneko I, Segawa H, Furutani J, Kuwahara S, Aranami F, Hanabusa E, Tominaga R, Giral H, Caldas Y, Levi M, Kato S, Miyamoto K 2011 Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+-dependent phosphate cotransporters. Pflugers Arch 461:77-90
10. Williams KB, DeLuca HF 2007 Characterization of intestinal phosphate absorption using a novel in vivo method. Am J Physiol Endocrinol Metab 292:E1917-E1921 (Pubitemid 47084731)
11. Kollenkirchen U, Fox J, Walters MR 1991 Normocalcemia without hyperparathyroidism in vitamin D-deficient rats. J Bone Miner Res 6:273-278
12. Brown AJ, Finch J, Grieff M, Ritter C, Kubodera N, Nishii Y, Slatopolsky E 1993 The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 133:1158-1164 (Pubitemid 23267767)
13. 2 with low calcemic activity in vivo. Biochem Pharmacol 68:1289-1296
14. 2 decreases with duration of treatment. J Am Soc Nephrol 11:2088-2094
15. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
16. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
17. Reinhardt TA, Horst RL, Orf JW, Hollis BW 1984 A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58:91-98 (Pubitemid 14220522)
18. Mizobuchi M, Ritter CS, Krits I, Slatopolsky E, Sicard G, Brown AJ 2009 Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res 24:1173-1179
19. Furuichi T, Kawata S, Asoh Y, Kumaki K, Ohyama Y 1998 Differential time course of induction of 1-α,25-dihydroxyvitamin D-3-24-hydroxylase mRNA expression in rats By 1-α,25-dihydroxyvitamin D-3 and its analogs. Life Sci 62:453-459 (Pubitemid 28018199)
20. Traebert M, Hattenhauer O, Murer H, Kaissling B, Biber J 1999 Expression of type II Na-P(i) cotransporter in alveolar type II cells. Am J Physiol 277:L868-L873
21. 3 receptors in rat lung during the perinatal period: regulation and immunohistochemical localization. Endocrinology 127:1755-1762
22. Ritter CS, Brown AJ 2011 Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism. J Cell Biochem 112:1348-1352
23. 3 derivative, on calcium metabolism. Biochem Biophys Res Commun 163:1444-1449
24. XuH, Bai L, Collins JF, Ghishan FK 2002 Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25- (OH)2 vitamin D3. Am J Physiol Cell Physiol 282:C487-C493 (Pubitemid 34663164)
25. 3. Endocrinol Metab Clin North Am 39:255-269, table of contents
26. Carlberg C, Seuter S, Heikkinen S 2012 The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 32:271-282